Wild type and mutant amyloid precursor proteins influence downstream effects of proteasome and autophagy inhibition

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 2, 2014, Pages 127-134

  Cecarini, Valentina ^a   Bonfili, Laura ^a   Cuccioloni, Massimiliano ^a   Mozzicafreddo, Matteo ^a   Rossi, Giacomo ^a   Keller, Jeffrey N ^b   Angeletti, Mauro ^a   Eleuteri, Anna Maria ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Amyloid precursor protein; Autophagy; Cathepsin B; Ubiquitin proteasome system

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CATHEPSIN B; GLYCINE; PROTEASOME; PROTEINASE; UBIQUITINATED PROTEIN; VALINE;

ARTICLE; AUTOPHAGY; CELL VIABILITY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION; WESTERN BLOTTING;

3-METHYLADENINE; 3MA; AMINOPEPTIDASE N; AMYLOID PRECURSOR PROTEIN; AMYLOID-Β; AP-N; APP; AUTOPHAGY; AΒ; BRAAP; BRANCHED-CHAIN AMINO ACIDS PREFERRING; CATHEPSIN B; CHT-L; CHYMOTRYPSIN-LIKE; IHC; IMMUNOHISTOCHEMISTRY; PEPTIDYLGLUTAMYL-PEPTIDE HYDROLYZING; PGPH; T-L; TRYPSIN-LIKE; UBIQUITIN-PROTEASOME SYSTEM; UPS;

ADENINE; AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN PRECURSOR; AUTOPHAGY; BLOTTING, WESTERN; CATHEPSIN B; CELL LINE, TUMOR; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUPEPTINS; MUTANT PROTEINS; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS;

EID: 84890212604     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.11.002     Document Type: Article

References (39)

1. Morawe T., Hiebel C., Kern A., Behl C. Protein homeostasis, aging and Alzheimer's disease. Mol. Neurobiol. 2012, 46:41-54.
2. Dasuri K., Zhang L., Keller J.N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 2013, 62:170-185.
3. Cecarini V., Bonfili L., Cuccioloni M., Mozzicafreddo M., Rossi G., Buizza L., Uberti D., Angeletti M., Eleuteri A.M. Crosstalk between the ubiquitin-proteasome system and autophagy in a human cellular model of Alzheimer's disease. Biochim. Biophys. Acta 2012, 1822:1741-1751.
4. Zheng Q., Li J., Wang X. Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies. Int. J. Physiol. Pathophysiol. Pharmacol. 2009, 1:127-142.
5. Park C., Cuervo A.M. Selective autophagy: talking with the UPS. Cell Biochem. Biophys. 2013, 64:3-13.
6. Ciechanover A. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Cell Death Differ. 2005, 12:1178-1190.
7. Orlowski M. The multicatalytic proteinase complex, a major extralysosomal proteolytic system. Biochemistry 1990, 29:10289-10297.
8. Wong E., Cuervo A.M. Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harb. Perspect. Biol. 2010, 2:a006734.
9. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
10. Yang Z., Klionsky D.J. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol. 2009, 335:1-32.
11. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012, 22:407-417.
12. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 2004, 6:463-477.
13. Li W.W., Li J., Bao J.K. Microautophagy: lesser-known self-eating. Cell. Mol. Life Sci. 2012, 69:1125-1136.
14. Klionsky D.J., C.P. The mechanism and physiological function of macroautophagy. J. Innate Immun. 2013, 5:427-433.
15. Arias E., Cuervo A.M. Chaperone-mediated autophagy in protein quality control. Curr. Opin. Cell Biol. 2011, 23:184-189.
16. van Tijn P., Dennissen F.J., Gentier R.J., Hobo B., Hermes D., Steinbusch H.W., Van Leeuwen F.W., Fischer D.F. Mutant ubiquitin decreases amyloid beta plaque formation in a transgenic mouse model of Alzheimer's disease. Neurochem. Int. 2012, 61:739-748.
17. Nilsson P., Loganathan K., Sekiguchi M., Matsuba Y., Hui K., Tsubuki S., Tanaka M., Iwata N., Saito T., Saido T.C. Abeta secretion and plaque formation depend on autophagy. Cell Rep. 2013, 5:61-69.
18. Reddy P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 2006, 96:1-13.
19. Reddy P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp. Neurol. 2009, 218:286-292.
20. Yana Michael H., Wanga Xinglong, Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med. 2013, 62:90-101.
21. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19318-19323.
22. Orlowski M., Michaud C. Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. Biochemistry 1989, 28:9270-9278.
23. Pfleiderer G. Isolation of an Aminopetidase from Kidney Particles, Methods in Enzymology 1970, Academic Press, New York, NY.
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
26. Amici M., Bonfili L., Spina M., Cecarini V., Calzuola I., Marsili V., Angeletti M., Fioretti E., Tacconi R., Gianfranceschi G.L., Eleuteri A.M. Wheat sprout extract induces changes on 20S proteasomes functionality. Biochimie 2008, 90:790-801.
27. Tchoupe T.M.J.R., Gauthier F., Bieth J.G. Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group. Biochim. Biophys. Acta 1991, 1076:149-151.
28. Shen Y.F., Tang Y., Zhang X.J., Huang K.X., Le W.D. Adaptive changes in autophagy after UPS impairment in Parkinson's disease. Acta Pharmacol. Sin. 2013, 34:667-673.
29. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldiner O., Padmanabhan R., Hild M., Berry D.L., Garza D., Hubbert C.C., Yao T.P., Baehrecke E.H., Taylor J.P. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
30. Pandey U.B., Batlevi Y., Baehrecke E.H., Taylor J.P. HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration. Autophagy 2007, 3:643-645.
31. Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:1889-1892.
32. Donohue E., Tovey A., Vogl A.W., Arns S., Sternberg E., Young R.N., Roberge M. Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin. J. Biol. Chem. 2011, 286:7290-7300.
33. Jullig M., Zhang W.V., Ferreira A., Stott N.S. MG132 induced apoptosis is associated with p53-independent induction of pro-apoptotic Noxa and transcriptional activity of beta-catenin. Apoptosis 2006, 11:627-641.
34. Skalniak L., Koj A., Jura J. Proteasome inhibitor MG-132 induces MCPIP1 expression. FEBS J. 2013, 280:2665-2674.
35. Cao Y., Klionsky D.J. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007, 17:839-849.
36. Bjorkoy G., Lamark T., Pankiv S., Overvatn A., Brech A., Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009, 452:181-197.
37. Ihara Y., Morishima-Kawashima M., Nixon R. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2.
38. Wang C., Sun B., Zhou Y., Grubb A., Gan L. Cathepsin B degrades amyloid-beta in mice expressing wild-type human amyloid precursor protein. J. Biol. Chem. 2012, 287:39834-39841.
39. Mueller-Steiner S., Zhou Y., Arai H., Roberson E.D., Sun B., Chen J., Wang X., Yu G., Esposito L., Mucke L., Gan L. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 2006, 51:703-714.